BISELCO Awards 15-Year Power Supply Deal To CIPC To Strengthen Palawan’s Energy Security

BISELCO has awarded a 15-year power supply deal to CIPC, aimed at enhancing Palawan’s energy security.

Vivant Hits Record PHP2.3 Billion Core Net Income In 2024 Amid Strong Growth

Vivant Corporation reports a remarkable 20% increase in consolidated core net income for 2024, reaching Php 2.3 billion.

ASUS Zenbook A14: The Lightest Zenbook AI Laptop Is In The Philippines

The Zenbook A14 is setting new standards in the world of lightweight laptops with its remarkable design. #PAGEONExASUS

GALLANT: Inspiring Local Champions, Awakening Global Potential

GALLANT is here to inspire local champions and awaken global potential. The time to step up is now.

Face Shields In PUVs Optional Under Alert Levels 1-3: DOTr

Face shields are no longer mandatory for commuters in areas under Alert Levels 1, 2, and 3!

Face Shields In PUVs Optional Under Alert Levels 1-3: DOTr

21
21

How do you feel about this story?

Like
Love
Haha
Wow
Sad
Angry

Face shields are no longer mandatory for commuters in areas under Alert Levels 1, 2, and 3, the Department of Transportation (DOTr) said on Tuesday.

This, after President Rodrigo Roa Duterte approved the recommendation of the Inter-Agency Task Force for the Management of Emerging Infectious Disease (IATF-EID) to make the wearing of face shields voluntary in areas under Alert Level 1 to 3.

DOTr Undersecretary for Administrative Services Artemio Tuazon Jr. said the new protocols on the use of face shields will be immediately enforced.

For areas under Alert Level 5 and granular lockdowns, he said face shields remain mandatory in “community settings.”

“For areas under Alert Level 4, local government units (LGUs) and private establishments are given the discretion to mandate the use of face shields,” Tuazon said in a statement on Tuesday.

Wearing face shields were mandatory in all modes of public transportation in the country since Aug. 15, 2020, as part of the country’s health and safety protocols against Covid-19. (PNA)